{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:15:37Z","timestamp":1791087337614,"version":"4.1.0"},"reference-count":79,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,9,1]],"date-time":"2007-09-01T00:00:00Z","timestamp":1188604800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Lymphoma and Myeloma"],"published-print":{"date-parts":[[2007,9]]},"DOI":"10.3816\/clm.2007.n.037","type":"journal-article","created":{"date-parts":[[2008,9,11]],"date-time":"2008-09-11T01:10:53Z","timestamp":1221095453000},"page":"524-534","source":"Crossref","is-referenced-by-count":28,"title":["Synthetic Imidazoquinolines Potently and Broadly Activate the Cellular Immune Response of Patients with Cutaneous T-Cell Lymphoma: Synergy with Interferon-\u03b3 Enhances Production of Interleukin-12"],"prefix":"10.3816","volume":"7","author":[{"given":"Maria","family":"Wysocka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Newton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernice M.","family":"Benoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Introcaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aidan S.","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihed","family":"Chehimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen K.","family":"Richardson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel M.","family":"Gelfand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis J.","family":"Montaner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain H.","family":"Rook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.3816\/CLM.2007.n.037_bib1","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1093616","article-title":"Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA","volume":"303","author":"Diebold","year":"2004","journal-title":"Science"},{"key":"10.3816\/CLM.2007.n.037_bib2","doi-asserted-by":"crossref","first-page":"5598","DOI":"10.1073\/pnas.0400937101","article-title":"Recognition of single-stranded RNA viruses by Toll-like receptor 7","volume":"101","author":"Lund","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.3816\/CLM.2007.n.037_bib3","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1126\/science.1093620","article-title":"Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8","volume":"303","author":"Heil","year":"2004","journal-title":"Science"},{"key":"10.3816\/CLM.2007.n.037_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/ni0602-499","article-title":"Human TLR7 or TLR8 independently confer responsiveness to the antiviral compound R-848","volume":"3","author":"Jurk","year":"2002","journal-title":"Nat Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib5","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1034\/j.1600-065X.2001.1820117.x","article-title":"Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells","volume":"182","author":"Weiner","year":"2001","journal-title":"Immunol Rev"},{"key":"10.3816\/CLM.2007.n.037_bib6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/ijc.2910310306","article-title":"Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes","volume":"31","author":"Ortaldo","year":"1983","journal-title":"Int J Cancer"},{"key":"10.3816\/CLM.2007.n.037_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0008-8749(82)90208-8","article-title":"Effect of human recombinant interferon on cytotoxic activity of natural killer (NK) cells and monocytes","volume":"67","author":"Herberman","year":"1982","journal-title":"Cell Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S1074-7613(00)80564-6","article-title":"Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15","volume":"8","author":"Zhang","year":"1998","journal-title":"Immunity"},{"key":"10.3816\/CLM.2007.n.037_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1172\/JCI110062","article-title":"Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides","volume":"67","author":"Haynes","year":"1981","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2007.n.037_bib10","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1182\/blood.V88.7.2385.bloodjournal8872385","article-title":"Mycosis fungoides and Sezary syndrome","volume":"88","author":"Diamandidou","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib11","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib12","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/archderm.1993.01680250098016","article-title":"The immunopathogenesis of cutaneous T-cell lymphoma. Abnormal cytokine production by Sezary T cells","volume":"129","author":"Rook","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib13","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib14","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/1523-1747.ep12388985","article-title":"Mycosis fungoides exhibits a Th1-type cell-mediated cytokine profile whereas Sezary syndrome expresses a Th2-type profile","volume":"103","author":"Saed","year":"1994","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib15","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/1523-1747.ep12326693","article-title":"Th2 cytokine profile in cutaneous T-cell lymphoma","volume":"105","author":"Lessin","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib16","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain)","volume":"88","author":"Dummer","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib17","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1182\/blood-2002-01-0231","article-title":"Sezary syndrome patients demonstrate a defect in dendritic cell populations: effects of CD40 ligand and treatment with GM-CSF on dendritic cell numbers and the production of cytokines","volume":"100","author":"Wysocka","year":"2002","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib18","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/archderm.138.8.1054","article-title":"Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib19","first-page":"29","article-title":"Cytokines and other biologic agents as immunotherapeutics for cutaneous T-cell lymphoma","volume":"18","author":"Rook","year":"2002","journal-title":"Adv Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib20","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-3-642-59410-6_37","article-title":"New biologic agents for the treatment of cutaneous T-cell lymphoma","volume":"160","author":"Vittorio","year":"2002","journal-title":"Recent Results Cancer Res"},{"key":"10.3816\/CLM.2007.n.037_bib21","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1172\/JCI200524826","article-title":"Immunopathogenesis and therapy of cutaneous T cell lymphoma","volume":"115","author":"Kim","year":"2005","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2007.n.037_bib22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jdermsci.2005.01.005","article-title":"Treatment with IFN-gamma increases serum levels of Th1 chemokines and decreases those of Th2 chemokines in patients with mycosis fungoides","volume":"38","author":"Hino","year":"2005","journal-title":"J Dermatol Sci"},{"key":"10.3816\/CLM.2007.n.037_bib23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1146\/annurev.immunol.20.083001.084359","article-title":"Innate immune recognition","volume":"20","author":"Janeway","year":"2002","journal-title":"Annu Rev Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/intimm\/dxh186","article-title":"Toll-like receptors in innate immunity","volume":"17","author":"Takeda","year":"2005","journal-title":"Int Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.smim.2003.10.004","article-title":"Toll-like receptors and dendritic cells: for whom the bug tolls","volume":"16","author":"Reis e Sousa","year":"2004","journal-title":"Semin Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib26","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archderm.138.9.1137","article-title":"Treatment of stage IA cutaneous T-cell lymphoma with topical application of the immune response modifier imiquimod","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib27","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4632.2004.02318.x","article-title":"Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis","volume":"44","author":"Majewski","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib28","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1067\/mjd.2001.113689","article-title":"Imiquimod 5% cream in the treatment of superficial basal cell carcinoma: results of a multicenter 6-week dose-response trial","volume":"44","author":"Marks","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib29","first-page":"555","article-title":"Topical imiquimod treatment of a cutaneous melanoma metastasis","volume":"43","author":"Steinmann","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000063904","article-title":"Imiquimod, a topical immune response modifier, in the treatment of cutaneous metastases of malignant melanoma","volume":"205","author":"Bong","year":"2002","journal-title":"Dermatology"},{"key":"10.3816\/CLM.2007.n.037_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1365-2133.2002.04945.x","article-title":"Imiquimod: a potential role in dermatology?","volume":"147","author":"Eedy","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib32","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.4049\/jimmunol.174.5.2476","article-title":"Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod","volume":"174","author":"Rechtsteiner","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib33","doi-asserted-by":"crossref","first-page":"7676","DOI":"10.4049\/jimmunol.174.12.7676","article-title":"Immunization with HIV-1 gag protein conjugated to a TLR7\/8 agonist results in the generation of HIV-1 gag-specific Th1 and CD8+ T cell responses","volume":"174","author":"Wille-Reece","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib34","doi-asserted-by":"crossref","first-page":"157","DOI":"10.4049\/jimmunol.176.1.157","article-title":"The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity","volume":"176","author":"Prins","year":"2006","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib35","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.4049\/jimmunol.174.3.1259","article-title":"Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8","volume":"174","author":"Gorden","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib36","doi-asserted-by":"crossref","first-page":"6567","DOI":"10.4049\/jimmunol.161.12.6567","article-title":"The role of Stat4 in speciesspecific regulation of Th cell development by type I IFNs","volume":"161","author":"Rogge","year":"1998","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib37","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0065-2776(08)60387-9","article-title":"Interleukin-12: a cytokine at the interface of inflammation and immunity","volume":"70","author":"Trinchieri","year":"1998","journal-title":"Adv Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib38","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/35021228","article-title":"Toll-like receptors in the induction of the innate immune response","volume":"406","author":"Aderem","year":"2000","journal-title":"Nature"},{"key":"10.3816\/CLM.2007.n.037_bib39","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/j.immuni.2004.10.006","article-title":"Toll-dependent control mechanisms of CD4 T cell activation","volume":"21","author":"Pasare","year":"2004","journal-title":"Immunity"},{"key":"10.3816\/CLM.2007.n.037_bib40","first-page":"131","article-title":"Cutaneous T-cell lymphoma","volume":"1","author":"Murphy","year":"1988","journal-title":"Adv Pathol"},{"key":"10.3816\/CLM.2007.n.037_bib41","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.jaad.2005.06.001","article-title":"Association of change in clinical status and change in the percentage of the CD4+CD26-lymphocyte population in patients with Sezary syndrome","volume":"53","author":"Introcaso","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib42","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1038\/sj.jidsp.5640188","article-title":"Photopheresis: clinical applications and mechanism of action","volume":"4","author":"Rook","year":"1999","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.3816\/CLM.2007.n.037_bib43","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.154.3.1491","article-title":"IL-12 reverses cytokine and immune abnormalities in Sezary syndrome","volume":"154","author":"Rook","year":"1995","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib44","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1084\/jem.170.3.827","article-title":"Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes","volume":"170","author":"Kobayashi","year":"1989","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S1074-7613(00)00070-4","article-title":"Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12","volume":"13","author":"Oppmann","year":"2000","journal-title":"Immunity"},{"key":"10.3816\/CLM.2007.n.037_bib46","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.4049\/jimmunol.175.3.1636","article-title":"TLR7\/8-mediated activation of human NK cells results in accessory cell-dependent IFNgamma production","volume":"175","author":"Hart","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib47","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1093\/intimm\/dxl046","article-title":"Distinct indirect pathways govern human NK-cell activation by TLR-7 and TLR-8 agonists","volume":"18","author":"Gorski","year":"2006","journal-title":"Int Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib48","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.4049\/jimmunol.154.8.3999","article-title":"IL-12 exacerbates rather than suppresses T helper 2-dependent pathology in the absence of endogenous IFN-gamma","volume":"154","author":"Wynn","year":"1995","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib49","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.4049\/jimmunol.158.6.2648","article-title":"Roles of IL-4 and IFN-gamma in stabilizing the T helper cell type 1 and 2 phenotype","volume":"158","author":"Nakamura","year":"1997","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib50","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/ni1223","article-title":"Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells","volume":"6","author":"Napolitani","year":"2005","journal-title":"Nat Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib51","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.161.4.2011","article-title":"IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression","volume":"161","author":"Hermann","year":"1998","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib52","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1084\/jem.178.3.1041","article-title":"Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor\/IL-12 synthesis in accessory cells","volume":"178","author":"D'Andrea","year":"1993","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib53","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1084\/jem.179.5.1563","article-title":"Effects of interleukin 12 on immune responses and host protection in mice infected with intestinal nematode parasites","volume":"179","author":"Finkelman","year":"1994","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib54","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1084\/jem.183.6.2559","article-title":"Interleukin-12 primes human CD4 and CD8 T cell clones for high production of both interferon-gamma and interleukin-10","volume":"183","author":"Gerosa","year":"1996","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib55","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1172\/JCI119162","article-title":"Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy","volume":"99","author":"Libraty","year":"1997","journal-title":"J Clin Invest"},{"key":"10.3816\/CLM.2007.n.037_bib56","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1084\/jem.20041964","article-title":"A type I interferon autocrine-paracrine loop is involved in Toll-like receptor-induced interleukin-12p70 secretion by dendritic cells","volume":"201","author":"Gautier","year":"2005","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib57","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1084\/jem.170.5.1751","article-title":"Recombinant interleukin 4 suppresses the production of interferon gamma by human mononuclear cells","volume":"170","author":"Peleman","year":"1989","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib58","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4049\/jimmunol.144.2.570","article-title":"IL-4 inhibits the synthesis of IFN-gamma and induces the synthesis of IgE in human mixed lymphocyte cultures","volume":"144","author":"Vercelli","year":"1990","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib59","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/sj.jid.5700121","article-title":"A role for regulatory T cells in cutaneous T-cell lymphoma; induction of a CD4 + CD25 + Foxp3+ T-cell phenotype associated with HTLV-1 infection","volume":"126","author":"Walsh","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.3816\/CLM.2007.n.037_bib60","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1084\/jem.189.3.521","article-title":"Type I interferons keep activated T cells alive","volume":"189","author":"Marrack","year":"1999","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib61","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1182\/blood-2004-03-1190","article-title":"Enhancement of the host immune responses in cutaneous T-cell lymphoma by CpG oligodeoxynucleotides and IL-15","volume":"104","author":"Wysocka","year":"2004","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib62","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1182\/blood.V87.7.2632.bloodjournal8772632","article-title":"Role of interleukin-15 in the development of human CD56+ natural killer cells from CD34+ hematopoietic progenitor cells","volume":"87","author":"Mrozek","year":"1996","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib63","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-065X.1998.tb01229.x","article-title":"Natural killer cell differentiation: insights from knockout and transgenic mouse models and in vitro systems","volume":"165","author":"Williams","year":"1998","journal-title":"Immunol Rev"},{"key":"10.3816\/CLM.2007.n.037_bib64","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1182\/blood.V97.1.14","article-title":"Interleukin 15: biology and relevance to human disease","volume":"97","author":"Fehniger","year":"2001","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib65","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1182\/blood-2003-01-0183","article-title":"IL-15 induces antigen-independent expansion and differentiation of human naive CD8+ T cells in vitro","volume":"102","author":"Alves","year":"2003","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib66","doi-asserted-by":"crossref","first-page":"5018","DOI":"10.4049\/jimmunol.170.10.5018","article-title":"IL-15 promotes the survival of naive and memory phenotype CD8+ T cells","volume":"170","author":"Berard","year":"2003","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib67","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1084\/jem.20020772","article-title":"Interleukin 15 controls both proliferation and survival of a subset of memory-phenotype CD8(+) T cells","volume":"196","author":"Judge","year":"2002","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib68","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.4049\/jimmunol.175.3.1551","article-title":"Direct stimulation of human T cells via TLR5 and TLR7\/8: flagellin and R-848 up-regulate proliferation and IFN-gamma production by memory CD4+ T cells","volume":"175","author":"Caron","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib69","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1113401","article-title":"Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function","volume":"309","author":"Peng","year":"2005","journal-title":"Science"},{"key":"10.3816\/CLM.2007.n.037_bib70","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib71","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1182\/blood.V86.2.646.bloodjournal862646","article-title":"Regulation of interleukin-12 expression in human monocytes: selective priming by interferon-gamma of lipopolysaccharide-inducible p35 and p40 genes","volume":"86","author":"Hayes","year":"1995","journal-title":"Blood"},{"key":"10.3816\/CLM.2007.n.037_bib72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1084\/jem.183.1.147","article-title":"The interleukin 12 p40 gene promoter is primed by interferon gamma in monocytic cells","volume":"183","author":"Ma","year":"1996","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib73","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1084\/jem.20030026","article-title":"Differential regulation of interleukin (IL)-12 p35 and p40 gene expression and interferon (IFN)-gamma\u2013primed IL-12 production by IFN regulatory factor 1","volume":"198","author":"Liu","year":"2003","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib74","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/S1521-6616(03)00060-3","article-title":"Type I IFNs differentially modulate IL-12p70 production by human dendritic cells depending on the maturation status of the cells and counteract IFNgamma-mediated signaling","volume":"107","author":"Heystek","year":"2003","journal-title":"Clin Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib75","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1084\/jem.177.2.523","article-title":"Interferon gamma inhibits interleukin 10 production by monocytes","volume":"177","author":"Chomarat","year":"1993","journal-title":"J Exp Med"},{"key":"10.3816\/CLM.2007.n.037_bib76","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1046\/j.1365-2249.1997.4661362.x","article-title":"Interferon-gamma (IFN-gamma) regulates production of IL-10 and IL-12 in human herpesvirus-6 (HHV-6)-infected monocyte\/macrophage lineage","volume":"109","author":"Li","year":"1997","journal-title":"Clin Exp Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib77","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.4049\/jimmunol.167.3.1423","article-title":"IL-12 induction by a TH1-inducing adjuvant in vivo: dendritic cell subsets and regulation by IL-10","volume":"167","author":"Huang","year":"2001","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib78","doi-asserted-by":"crossref","first-page":"4860","DOI":"10.4049\/jimmunol.174.8.4860","article-title":"Molecular basis for the potency of IL-10-deficient dendritic cells as a highly efficient APC system for activating Th1 response","volume":"174","author":"He","year":"2005","journal-title":"J Immunol"},{"key":"10.3816\/CLM.2007.n.037_bib79","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1365-2141.2004.04984.x","article-title":"Either interleukin-12 or interferongamma can correct the dendritic cell defect induced by transforming growth factor beta in patients with myeloma","volume":"125","author":"Brown","year":"2004","journal-title":"Br J Haematol"}],"container-title":["Clinical Lymphoma and Myeloma"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1557919011701019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T22:10:58Z","timestamp":1738361458000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1557919011701019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9]]},"references-count":79,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,9]]}},"alternative-id":["S1557919011701019"],"URL":"https:\/\/doi.org\/10.3816\/clm.2007.n.037","relation":{},"ISSN":["1557-9190"],"issn-type":[{"value":"1557-9190","type":"print"}],"subject":[],"published":{"date-parts":[[2007,9]]}}}